The Claim
Weekly supplementation with 50,000 IU of cholecalciferol for three months in women with Hashimoto's thyroiditis is associated with a significant reduction in interleukin-17 gene expression and serum levels.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with Hashimoto's thyroiditis, taking 50,000 IU of vitamin D weekly for three months is associated with lower levels of interleukin-17 in the blood and reduced activity of the gene that produces it.
See the scientific wording
In women with Hashimoto's thyroiditis, weekly supplementation with 50,000 IU of cholecalciferol for three months is associated with a significant reduction in interleukin-17 (IL-17) gene expression and serum levels, suggesting a modulatory effect on Th17-driven inflammation, a key pathway in autoimmune thyroid destruction.
When vitamin D enters immune cells, it turns on genes that stop the production of a harmful inflammatory signal called IL-17 and turns on genes that boost a calming signal called TGF-beta. This shifts the immune system away from attacking the thyroid and toward calming down the response.
What the research says
1 studyThe study gave women with Hashimoto's vitamin D and saw IL-17 levels go down, but so did the group that got a fake pill — so we can't say the vitamin D actually caused the drop.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.